Patent · US Active

Methods targeting miR-128 for regulating cholesterol/lipid metabolism

US9476046B2 · kind B2 · utility

3Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2015
Grant dateOct 25, 2016
Priority date—
Expiry dateApr 30, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.